MCESF News 4.6450 Macro Enterprises (MCESF)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Macro Enterprises (MCESF) 4.6450 $MCESF

Macro Enterprises Inc. Announces 2013 Fourth Quarter and Year End Results
Marketwire - Wed Mar 12, 5:21PM CDT
Macro Enterprises Inc. (TSX VENTURE: MCR) -

Macro Enterprises Inc. Announces Date of Release of Fourth Quarter and Year End Financial Results and Conference Call Information
Marketwire - Tue Mar 11, 1:39PM CDT
Macro Enterprises Inc. (the "Company" or "Macro" (TSX VENTURE: MCR) will release its 2013 fourth quarter and year end financial results at the close of market on Wednesday, March 12, 2014.

Macro Enterprises Inc. Announces Correction to 2013 Third Quarter Results News Release
Marketwire - Fri Nov 29, 6:31PM CST
Macro Enterprises Inc. (TSX VENTURE: MCR) (the "Company" or "Macro" wishes to point out that the Weighted average common shares outstanding (thousands) of 25,120 disclosed in its news release issued earlier today is incorrect. The correct Weighted average common shares outstanding (thousands) for the third quarter is 26,663, as disclosed in the financial statements. An updated release including the corrected number has been filed and is available on SEDAR at www.sedar.com.

Macro Enterprises Inc. Announces 2013 Third Quarter Results
Marketwire - Fri Nov 29, 3:28PM CST
Macro Enterprises Inc. (TSX VENTURE: MCR) --

Smallcappower.com Daily Investment Idea: Canadian Energy Stocks to Watch on Rising Oil Prices Include Raise Production Inc., Macro Enterprises Inc. and Alter Nrg Corp
Newsfile Corp - Wed Aug 28, 8:53AM CDT
full story)

Macro Enterprises Inc. Announces 2013 Second Quarter Results
Marketwire - Tue Aug 20, 3:20PM CDT
Macro Enterprises Inc. (TSX VENTURE: MCR) -

Stockboard Custom Reports on Macro Enterprises Inc. and Celestica Inc.
ACCESSWIRE - Tue Jul 30, 8:02AM CDT
Custom stock reports and email news alert service for Macro Enterprises Inc. (TSX VENTURE:MCR) and Celestica Inc. (NYSE: CLS)(TSX: CLS) are now available on Stockboard.com

Macro Enterprises Inc. Announces Issuance of Common Shares upon Conversion of Loan
Marketwire - Mon Jun 24, 6:33PM CDT
Further to the news releases issued by Macro Enterprises Inc. (TSX VENTURE: MCR) (the "Company" or "Macro" dated June 3, 2013 and June 18, 2013, Macro announces that pursuant to the terms of a Convertible Loan Agreement dated July 7, 2006, as amended, (the "Convertible Loan Agreement", it has issued an aggregate of 3,792,698 Common shares in satisfaction of $5,689,051, being the aggregate principal amount of the loan at a conversion price of $1.50 per Common share. Certain of the lenders to whom Common shares were issued upon such conversion, namely Frank Miles, Mark Dodge and Hugh Sewell, are insiders of Macro. A copy of the Convertible Loan Agreement, as amended, is available on SEDAR at www.sedar.com.

Frank Miles: News Release
Marketwire - Mon Jun 24, 6:26PM CDT
Frank Miles of 7904 101 Avenue, Fort St. John, British Columbia, announces that he has acquired direct beneficial ownership of 2,341,234 Common shares (the "Conversion Shares" of Macro Enterprises Inc. ("Macro". The Conversion Shares were acquired upon conversion of a loan owing to Mr. Miles from Macro in the aggregate principal amount of $3,511,851.40 at a conversion price of $1.50 per Common share, all pursuant to the terms of a Convertible Loan Agreement dated July 7, 2006 between Mr. Miles, Macro, Macro Industries Inc. and certain other lenders, as amended (the "Convertible Loan Agreement".

Macro Enterprises Inc. Announces Approval of Amendment to Convertible Loan Agreement
Marketwire - Tue Jun 18, 5:26PM CDT
Macro Enterprises Inc. (TSX VENTURE: MCR) (the "Company" or "Macro" announces that it has received approval from the TSX Venture Exchange and approval from the Company's disinterested Common shareholders of an amendment to the Convertible Loan Agreement, as amended, dated July 7, 2006 among the Company, its wholly-owned subsidiary, Macro Industries Inc., and certain lenders. Particulars of the amendment are set out in the Company's Information Circular dated April 10, 2013 which, together with a copy of the amended Convertible Loan Agreement, are available on SEDAR at www.sedar.com. As announced by the Company on June 3, 2013, the lenders have given notice of their intention to convert the principal amount of the loan to Common shares.

Macro Enterprises Inc. Announces Impending Distribution of Shares Pursuant to Convertible Loan Agreement
Marketwire - Mon Jun 03, 8:25AM CDT
Macro Enterprises Inc. (the "Company" or "Macro" (TSX VENTURE: MCR) announces that the lenders to Macro under the terms of a Convertible Loan Agreement, as amended, dated July 7, 2006 among the lenders, Macro and its wholly- owned subsidiary, Macro Industries Inc. have given Macro notice of their intention to request that Macro issue an aggregate of 3,792,701 Common shares to the lenders in satisfaction of $5,689,051, being the aggregate principal amount of the loan at a conversion price of $1.50 per common share. The TSX Venture Exchange has approved the issuance of the common shares to the lenders, including the following three lenders who are insiders of Macro: Frank Miles, Mark Dodge and Hugh Sewell. Particulars of the loan agreement, were set out in Macro's news release dated March 28, 2012, and a copy of the loan agreement is available on SEDAR at www.sedar.com.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
PexarBolt's CES Honor Meets a Real Crowdfunding Test

Updated Category News Views 77

A little touchscreen bolted onto a dock would usually make me roll my eyes. This time, Pexar has at least put enough muscle behind the gimmick to deserve a harder look. The PexarBolt Ultra TBT5 Dock was named a CES Innovation Awards 2027 Honoree in Computer Peripherals & Accessories, following an IFA 2026 Innovation Awards honor only two months after its launch. Awards do...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 72

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 87

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 32

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 100

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 40

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Significant Unusual Options Activity Signals Opportunity in GOOGL

Updated Category News Views 97

Analyzing Recent Options Activity for Alphabet Currently, investors are exhibiting a strong bullish sentiment towards Alphabet (NASDAQ: GOOGL), a trend that is capturing the attention of market participants. Recent observations of public options have revealed significant movements in GOOGL, hinting at potential changes ahead. Recent analyses have uncovered 129 unusual...

Continue Reading
Encore and UKG Introduce Innovative Overtime Savings Program

Updated Category News Views 298

Encore and UKG Join Forces for Employee Financial Wellness Encore, a prominent global leader in event technology and production services, has unveiled an innovative ‘Overtime Savings Program’ in collaboration with UKG, a top provider of HR and workforce management solutions. This remarkable initiative aims to empower Encore's frontline workers, allowing them to save...

Continue Reading
Discover Incredible Returns from Texas Pacific Land Investments

Updated Category News Views 160

The Incredible Growth of Texas Pacific Land Corp Texas Pacific Land Corp (NYSE: TPL) has marked its presence in the market with an outstanding performance over the past 15 years. The company has outshone the market median by an impressive 32.71% annually, which translates to a staggering average annual return of 45.46%. With a current market capitalization nearing $20.51...

Continue Reading
Cypherpunk Q2 2026: Zcash Growth Sparks Market Buzz

Updated Category News Views 76

Cypherpunk Technologies' Stellar Q2 Performance Sit tight, folks, because Cypherpunk Technologies just unleashed a financial update that's got the market buzzing. They've reported a staggering net income of $39.4 million for Q2 2026, quite the turnaround from a $16.6 million loss in the same quarter last year. It's a serious win, no doubt pumped up by their fruitful Zcash...

Continue Reading
Exciting Findings from Aicuris’ Clinical Trials of AIC468

Updated Category News Views 182

Encouraging Insights into AIC468 from Clinical Trials Recently, a notable advancement in medical research has emerged from Aicuris Anti-infective Cures AG regarding its novel treatment, AIC468. This drug is an innovative antisense oligonucleotide targeting the BK virus, particularly in kidney transplant recipients. The first-in-human (FIH) Phase 1 trial has provided...

Continue Reading